Zimmer Biomet Holdings Inc (NYSE: ZBH) Up 11.41% From 52-Week Low; YTD Falls -5.39% – Here’s What To Do Now

Zimmer Biomet Holdings Inc (NYSE:ZBH)’s traded shares stood at 1.88 million during the last session, with the company’s beta value hitting 1.02. At the close of trading, the stock’s price was $115.14, to imply a decrease of -1.02% or -$1.19 in intraday trading. The ZBH share’s 52-week high remains $147.50, putting it -28.1% down since that peak but still an impressive 11.41% since price per share fell to its 52-week low of $102.00. The company has a valuation of $23.69B, with an average of 1.23 million shares over the past 3 months.

Zimmer Biomet Holdings Inc (NYSE:ZBH) trade information

After registering a -1.02% downside in the last session, Zimmer Biomet Holdings Inc (ZBH) has traded red over the past five days. The stock hit a weekly high of 120.13, dropping -1.02% in its intraday price action. The 5-day price performance for the stock is -3.24%, and -5.40% over 30 days. With these gigs, the year-to-date price performance is -5.39%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Zimmer Biomet Holdings Inc (ZBH) estimates and forecasts

Looking at statistics comparing Zimmer Biomet Holdings Inc share performance against respective industry, we note that the company has underperformed competitors. Zimmer Biomet Holdings Inc (ZBH) shares are 1.14% up over the last 6 months, with its year-to-date growth rate lower than industry average at 7.28% against 12.60%. The rating firms project that company’s revenue will grow 4.80% compared to the previous financial year.

Revenue forecast for the current quarter as set by 21 analysts is 1.94B. Meanwhile, for the current quarter, a total of 21 analyst(s) estimate revenue growth to 1.86B.Earnings reports from the last fiscal year show that sales brought in 1.82B and 1.75B respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 6.20% before jumping 6.20% in the following quarter.

ZBH Dividends

Zimmer Biomet Holdings Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Zimmer Biomet Holdings Inc has a forward dividend ratio of 0.96, with the share yield ticking at 0.83% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.